Comparative antimicrobial activity and kill-curve investigations of novel ketolide antimicrobial agents (HMR 3004 and HMR 3647) tested against Haemophilus influenzae and Moraxella catarrhalis strains

Diagnostic Microbiology and Infectious Disease

Volumn 31, Issue 2, 1998, Pages 349-353

  Biedenbach, Douglas J ^a   Barrett, Mary S ^a   Jones, Ronald N ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT; AZITHROMYCIN; BETA LACTAMASE; CIPROFLOXACIN; CLARITHROMYCIN; DALFOPRISTIN PLUS QUINUPRISTIN; DIRITHROMYCIN; ERYTHROMYCIN; HMR 3004; KETOLIDE; MACROLIDE; ROXITHROMYCIN; TELITHROMYCIN; UNCLASSIFIED DRUG;

ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIOSTASIS; CONTROLLED STUDY; DRUG POTENCY; HAEMOPHILUS INFLUENZAE; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; HAEMOPHILUS INFLUENZAE; KETOLIDES; MACROLIDES; MICROBIAL SENSITIVITY TESTS; MORAXELLA (BRANHAMELLA) CATARRHALIS;

EID: 0031780527     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(98)00022-4     Document Type: Article

References (15)

1. Agouridas C, Beneditti Y, Bonnefoy A, Collette P, Denis A, Mauvais P, Labbe G, Chantot JF (1996) Ketolides: a new class of macrolide antibacterials. Structural characteristics and biological properties of RU 004, abstr. 14.10. p. 97. In: Program and Abstracts of the 3rd International Conference on the Macrolides, Azalides, and Streptogramins. Lisbon, Portugal, p. 97.
2. Agouridas C., Bonnefoy A., Chantot J.F. Antibacterial activity of RU 64004 (HMR 3004), a novel ketolide derivative active against respiratory pathogens. Antimicrob Agents Chemother. 41:1997;2149-2158.
3. Bornstein N., Behr H., Burn Y., Fleurette J. In vitro activity of RU 004 on Legionella species, abstr. F166. Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA. 1995;142 American Society for Microbiology, Washington, DC.
4. Dabernat H., Seguy M., Delmas C. In vitro activity of RU 004 against Haemophilus influenzae and Moraxella catarrhalis, abstr. F161. Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA. 1995;141 American Society for Microbiology, Washington, DC.
5. Ednie L.M., Jacobs M.R., Appelbaum P.C. Comparative antianaerobic activities of the ketolides HMR 3647 (RU 66647) and HMR 3004 (RU 64004). Antimicrob Agents Chemother. 41:1997;2019-2022.
6. Jamjian C., Biedenbach D.J., Jones R.N. In vitro evaluation of a novel ketolide antimicrobial agent, RU-64004. Antimicrob Agents Chemother. 41:1997;454-459.
7. Jones R.N., Biedenbach D.J. Antimicrobial activity of RU-66647, a new ketolide. Diagn Microbiol Infect Dis. 27:1997;7-12.
8. Jorgensen J.H., Doern G.V., Maher L.A., Howell A.W., Redding J.S. Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States. Antimicrob Agents Chemother. 34:1990;2075-2080.
9. Marchant C.D. Spectrum of disease due to Branhamella catarrhalis in children with particular reference to acute otitis media. Am J Med. 88:(5A):1990;15S-19S.
10. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. Approved Standard M7-A4. 4th ed. 1997;National Committee for Clinical Laboratory Standards, Wayne, PA.
11. Methods for Determining Bactericidal Activity of Antimicrobial Agents Tentative Guidelines. M26-P. 1997;National Committee for Clinical Laboratory Standards, Wayne, PA.
12. Pankuch G.A., Jacobs M.R., Appelbaum P.C. MIC and time-kill study of antipneumococcal activities of RPR 106972 (a new oral streptogramin), RP 59500 (quinupristin-dalfopristin), pyostacine (RP 7293), penicillin G, cefotaxime, erythromycin, and clarithromycin against 10 penicillin-susceptible and -resistant pneumococci. Antimicrob Agents Chemother. 40:1996;2071-2074.
13. Rajagopalan-Levasseur P., Vallee E., Agourdias C., Chantot J.F., Pocidalo J.J. RU 004 activity against erythromycin-resistant pneumococci and Haemophilus influenzae in murine pneumonia models, abstr. F173 . Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA. 1995;143 American Society for Microbiology, Washington, DC.
14. Renaudin H., Aydin M.D., Bebear C. Ketolides and mycoplasmas in vitro evaluation of RU 004, abstr. F168 . Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA. 1995;142 American Society for Microbiology, Washington, DC.
15. Rittenhouse S.F., Miller L.A., Kaplan R.L., Mosely G.V., Poupard J.A. A survey of β-lactamase-producing Haemophilus influenzae an evaluation of 5750 isolates . Diagn Microbiol Infect Dis. 21:1995;223-225.